• IPS Biopharma AG

    BE
    active
    Check credit rating Timeline
    Check credit ratingCredit rating
    Register number: CH-036.3.057.747-6
    Sector: Research and development

    Age of the company

    12 years

    Turnover in CHF

    PremiumPremium

    Capital in CHF

    100'000

    Employees

    PremiumPremium

    Active brands

    0

    Reports for IPS Biopharma AG

    *displayed reports are examples
    preview

    Credit rating information

    Evaluation of credit rating with traffic light as risk indicator and other helpful data about the company.
    Find out more
    preview

    Economic information

    Comprehensive information about the economic situation of a company.
    Find out more
    preview

    Payment behaviour

    Assessment of the payment behaviour based on past invoices.
    Find out more
    preview

    Payment collection information

    Overview of current and past debt enforcement proceedings.
    Find out more
    preview

    Company dossier as PDF

    Contact information, changes in the company, turnover and employee figures, management, ownership, shareholding structure and other company data.
    Retrieve company dossier

    About IPS Biopharma AG

    • IPS Biopharma AG is a Company limited by shares (AG) with its legal headquarters in Bern. IPS Biopharma AG belongs to the industry «Research and development» and is currently active.
    • The management consists of 5 persons. The company was founded on 16.07.2013.
    • All past changes can be viewed and saved as a PDF under the section «Notifications». The last change in the commercial register was made on 23.11.2021.
    • The company IPS Biopharma AG is registered under the UID CHE-188.867.843.
    • On the same address as IPS Biopharma AG there are 20 other active companies registered. These include: Aikeso GmbH, Alexis Technologies AG, AlveoliX AG.

    Commercial register information

    Source: SOGC

    Sector

    Research and development

    Purpose (Original language)

    Die Gesellschaft bezweckt die Erforschung, die Entwicklung, die Herstellung und den Vertrieb immuntherapeutischer, pharmazeutischer sowie medizinischer Behandlungsmethoden gegen Krebs und andere Krankheiten. Die Gesellschaft kann im In- und Ausland Zweigniederlassungen errichten, sich an anderen Unternehmen im In- und Ausland beteiligen, gleichartige oder verwandte Unternehmen erwerben oder sich mit solchen zusammenschliessen, Grundstücke erwerben, verwalten und veräussern sowie alle Geschäfte eingehen und Verträge abschliessen, die geeignet sind, den Zweck der Gesellschaft zu fördern, oder die direkt oder indirekt damit im Zusammenhang stehen.

    Customise the company purpose with just a few clicks.

    Other company names

    Source: SOGC

    Es sind keine früheren oder übersetzten Firmannamen vorhanden.

    Would you like to update the company name? Click here.

    Branches (0)

    Ownership structure

    No information on the ownership structure is known to us.

    Holdings

    No information on holdings is known to us.

    Newest SOGC notifications: IPS Biopharma AG

    The latest updates from the Swiss Official Gazette of Commerce (SOGC) are available in the original language of the source commercial register office only. View all notifications

    SOGC 211123/2021 - 23.11.2021
    Categories: Change of company address

    Publication number: HR02-1005339961, Commercial Registry Office Berne, (36)

    IPS Biopharma AG, in Nidau, CHE-188.867.843, Aktiengesellschaft (SHAB Nr. 151 vom 07.08.2015, S.0, Publ. 2312069).

    Statutenänderung:
    14.10.2021.

    Sitz neu:
    Bern.

    Domizil neu:
    Freiburgstrasse 3, 3010 Bern.

    SOGC 151/2015 - 07.08.2015
    Categories: Change of company address

    Publication number: 2312069, Commercial Registry Office Berne, (36)

    IPS Biopharma AG, in Bern, CHE-188.867.843, Aktiengesellschaft (SHAB Nr. 65 vom 07.04.2015, Publ. 2080853).

    Statutenänderung:
    16.06.2015.

    Sitz neu:
    Nidau.

    Domizil neu:
    Aarbergstrasse 5, 2560 Nidau.

    SOGC 65/2015 - 07.04.2015
    Categories: Change in management

    Publication number: 2080853, Commercial Registry Office Berne, (36)

    IPS Biopharma AG, in Bern, CHE-188.867.843, Aktiengesellschaft (SHAB Nr. 138 vom 19.07.2013, Publ. 987761).

    Ausgeschiedene Personen und erloschene Unterschriften:
    Riedo, Donat, von Alterswil, in Giffers, Direktor, mit Einzelunterschrift.

    Eingetragene Personen neu oder mutierend:
    Visarius, Theresa Marie, von Hasle bei Burgdorf, in Hasle bei Burgdorf, Direktorin, mit Einzelunterschrift.

    Hit list

    Here you will find a link from the management to a hit list of persons with the same name who are registered in the commercial register.

    Title
    Confirm